Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1975 Apr;53(4):585–592. doi: 10.1111/j.1476-5381.1975.tb07398.x

Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.

I Kennedy, G P Levy
PMCID: PMC1666313  PMID: 238705

Abstract

1. AH 5158, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide, competitively antagonised phenylephrine-induced vasopressor responses in anaesthetized dogs, thus confirming that the drug possesses alpha-adrenoceptor blocking activity. 2. In contrast, AH 5158 was a relatively ineffective antagonist of vasopressor responses to noradrenaline in anesthetized dogs. Thus, at the lowest dose-level tested (1 mg/kg) AH 5158 abolished the increase in pulse width caused by noradrenaline, but otherwise had little or no blocking effect in doses as high as 10 mg/kg. Propranolol (0.1 mg/kg) also abolished the increase in pulse width caused by noradrenaline. With both drugs this effect is thought to be a consequence of blockade of the beta-adrenoceptor-mediated cardia stimulant action of noradrenaline. 3. The interaction between AH 5158 and noradrenaline in spinal dogs, anaesthetized cats and pithed rats was very similar to that seen in anaesthetized dogs. 4. Noradrenaline pressor responses were effectively antagonized by AH 5158 in anaesthetized dogs pretreated with cocaine. The degree of block was similar to that obtained when phenylephrine was the agonist in untreated dogs. 5. These results are consistent with the hypothesis that AH 5158 blocks a cocaine-sensitive inactivation process for noradrenaline in addition to blocking alpha- and beta-adrenoceptors. The resultant increase in the level of circulating noradrenaline would tend to counteract the adrenoceptor blocking action of the drug. 6. The implications of these findings are discussed.

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alabaster V. A., Bakhle Y. S. The removal of noradrenaline in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1973 Feb;47(2):325–331. doi: 10.1111/j.1476-5381.1973.tb08330.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boakes A. J., Knight E. J., Prichard B. N. Preliminary studies of the pharmacological effects of 5-[1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)-ethyl] salicylamide (AH 5158) in man. Clin Sci. 1971 Apr;40(4):18P–19P. doi: 10.1042/cs040018pa. [DOI] [PubMed] [Google Scholar]
  4. Collier J. G., Dawnay N. A., Nachev C., Robinson B. F. Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A. Br J Pharmacol. 1972 Feb;44(2):286–293. doi: 10.1111/j.1476-5381.1972.tb07265.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Farmer J. B., Kennedy I., Levy G. P., Marshall R. J. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol. 1972 Aug;45(4):660–675. doi: 10.1111/j.1476-5381.1972.tb08125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Iversen L. L. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol. 1971 Apr;41(4):571–591. doi: 10.1111/j.1476-5381.1971.tb07066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Iwasawa Y., Gillis C. N. Pharmacological analysis of norepinephrine and 5-hydroxytryptamine removal from the pulmonary circulation: differentiation of uptake sites for each amine. J Pharmacol Exp Ther. 1974 Feb;188(2):386–393. [PubMed] [Google Scholar]
  8. Shanks R. G. The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog. Br J Pharmacol Chemother. 1966 Feb;26(2):322–333. doi: 10.1111/j.1476-5381.1966.tb01911.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. TRENDELENBURG U., MUSKUS A., FLEMING W. W., GOMEZ ALONSO de la SIERRA B. Modification by reserpine of the action of sympathomimetic amines in spinal cats; a classification of sympathomimetic amines. J Pharmacol Exp Ther. 1962 Nov;138:170–180. [PubMed] [Google Scholar]
  10. WHITBY L. G., AXELROD J., WEIL-MALHERBE H. The fate of H3-norepinephrine in animals. J Pharmacol Exp Ther. 1961 May;132:193–201. [PubMed] [Google Scholar]
  11. WHITBY L. G., HERTTING G., AXELROD J. Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature. 1960 Aug 13;187:604–605. doi: 10.1038/187604a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES